These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 12897882)
21. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. Luna-Pérez P; Bustos-Cholico E; Alvarado I; Maffuz A; Rodríguez-Ramírez S; Gutiérrez de la Barrera M; Labastida S J Surg Oncol; 2005 Apr; 90(1):20-5. PubMed ID: 15786412 [TBL] [Abstract][Full Text] [Related]
22. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
23. Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Peschaud F; Cuenod CA; Benoist S; Julié C; Beauchet A; Siauve N; Taieb-Kasbi F; Penna C; Nordlinger B Dis Colon Rectum; 2005 Aug; 48(8):1603-9. PubMed ID: 15937629 [TBL] [Abstract][Full Text] [Related]
24. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173 [TBL] [Abstract][Full Text] [Related]
25. Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial. Verleye L; Ottevanger PB; Kristensen GB; Ehlen T; Johnson N; van der Burg ME; Reed NS; Verheijen RH; Gaarenstroom KN; Mosgaard B; Seoane JM; van der Velden J; Lotocki R; van der Graaf W; Penninckx B; Coens C; Stuart G; Vergote I Eur J Cancer; 2011 Jan; 47(1):57-64. PubMed ID: 20850296 [TBL] [Abstract][Full Text] [Related]
26. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069 [TBL] [Abstract][Full Text] [Related]
27. Retroperitoneal margin involvement by adenocarcinoma of the caecum and ascending colon: what does it mean? Scott N; Jamali A; Verbeke C; Ambrose NS; Botterill ID; Jayne DG Colorectal Dis; 2008 Mar; 10(3):289-93. PubMed ID: 17764533 [TBL] [Abstract][Full Text] [Related]
28. Investigation of circumferential resection margin in rectal cancer surgery. Dardanov D; Betova T; Deliyski T J BUON; 2007; 12(3):369-76. PubMed ID: 17918291 [TBL] [Abstract][Full Text] [Related]
29. Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Dent OF; Haboubi N; Chapuis PH; Chan C; Lin BP; Wong SK; Bokey EL Colorectal Dis; 2007 Feb; 9(2):112-21; discussion 121-2. PubMed ID: 17223934 [TBL] [Abstract][Full Text] [Related]
30. Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma. Tzardi M Dig Dis; 2007; 25(1):51-5. PubMed ID: 17384508 [TBL] [Abstract][Full Text] [Related]
32. Do MRI reports contain adequate preoperative staging information for end users to make appropriate treatment decisions for rectal cancer? Al-Sukhni E; Messenger DE; Charles Victor J; McLeod RS; Kennedy ED Ann Surg Oncol; 2013 Apr; 20(4):1148-55. PubMed ID: 23143592 [TBL] [Abstract][Full Text] [Related]
33. [Colorectal cancer--experiences with the use of standardized forms for reporting pathologic-anatomic data]. Bjugn R; Dirdal HU Tidsskr Nor Laegeforen; 2001 May; 121(14):1697-701. PubMed ID: 11446012 [TBL] [Abstract][Full Text] [Related]
34. Recommendations for the reporting of pleural mesothelioma. Butnor KJ; Sporn TA; Ordonez NG; Hum Pathol; 2007 Nov; 38(11):1587-9. PubMed ID: 17276491 [TBL] [Abstract][Full Text] [Related]
35. Electronic capture and communication of synoptic cancer data elements from pathology reports: results of the Reporting Pathology Protocols 2 (RPP2) project. Hassell L; Aldinger W; Moody C; Winters S; Gerlach K; Schwenn M; Perriello D J Registry Manag; 2009; 36(4):117-24; quiz 163-5. PubMed ID: 20795553 [TBL] [Abstract][Full Text] [Related]
36. Curative rectal cancer surgery in a low-volume hospital: a quality assessment. Debes AJ; Størkson RH; Jacobsen MB Eur J Surg Oncol; 2008 Apr; 34(4):382-9. PubMed ID: 17669613 [TBL] [Abstract][Full Text] [Related]
37. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. García-Granero E; Faiz O; Muñoz E; Flor B; Navarro S; Faus C; García-Botello SA; Lledó S; Cervantes A Cancer; 2009 Aug; 115(15):3400-11. PubMed ID: 19479978 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295 [TBL] [Abstract][Full Text] [Related]
40. An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines. Siddiqui MRS; Shanmuganandan AP; Rasheed S; Tekkis P; Brown G; Abulafi AM Eur J Surg Oncol; 2017 Nov; 43(11):2093-2104. PubMed ID: 28947340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]